Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea. - Wikidata - awgldk - TriplyDB

Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea.

Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea.

http://www.wikidata.org/entity/Q37598818

about

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients Inhibition of the VEGF signalling pathway and glomerular disorders.Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma.Risks associated with sunitinib use and monitoring to improve patient outcomes.Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.Dasatinib-induced nephrotic syndrome.When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: a case report.Focal segmental glomerulosclerosis lesion associated with inhibition of tyrosine kinases by lenvatinib: a case report

P2860

Q28080163-AFA999BE-FD51-4915-A8BE-0329656EF7FB Q38284055-293E4719-8B57-46E7-8BCB-C86D06AB3A8F Q40189187-EAFD726C-FE85-4855-8F6A-1AB2DA07B234 Q42433181-3AB95125-2C37-4389-B066-0961AC287585 Q47593350-9E58B6C7-EB72-4BD6-AA41-4496BC4C4E59 Q54242433-C5C0853B-2BA7-4F82-B5FC-57D33AD6BA57 Q54982000-94FD7400-D061-4EDA-A1B3-70409B169DA5 Q57809492-9198DC0C-1860-444D-97AB-B6E1159A8B39

P2860

Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea.

http://www.wikidata.org/entity/Q37598818

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Renal adverse effects of sunit ...... le-center experience in Korea.

@en

Renal adverse effects of sunit ...... le-center experience in Korea.

@nl

type

label

Renal adverse effects of sunit ...... le-center experience in Korea.

@en

Renal adverse effects of sunit ...... le-center experience in Korea.

@nl

prefLabel

Renal adverse effects of sunit ...... le-center experience in Korea.

@en

Renal adverse effects of sunit ...... le-center experience in Korea.

@nl

P1433

Q37598818-427DE670-B413-4CC8-96E2-E07BDFA9B7CE

P1476

Q37598818-BFDA27E7-ECC1-4ED7-99D0-36CC78DD09A8

P2093

Q37598818-199AAFDE-9758-4F4B-AFB2-430008544D20

Q37598818-5C75FC4D-37DC-4951-9780-6FF9FDDC67D5

Q37598818-7AB2295E-3583-4EF1-B032-FC1FBAA9599F

Q37598818-7FC93BEC-EEC1-4C15-8BFF-DFE47FD3ACBC

Q37598818-9A6AC385-99F7-48A0-AE12-94F5782BCCBA

Q37598818-9CCABB6B-A59A-4151-926A-84B1E649EC62

Q37598818-C08E3AED-32CC-4D3D-98FB-4BBF67B40E69

Q37598818-C43526B8-0893-4178-9D72-C9E78BCA4379

Q37598818-C4FF17A8-BBE5-4C3F-8425-5451E14E29D0

Q37598818-DCA7E780-AFEB-47DC-8F14-B00411272FDA

P2860

Q37598818-0FDFF280-7621-4B46-8F7F-FE7D6EFC33DE

Q37598818-1037749C-C5EE-4C33-A5D5-1BFB3C1E138C

Q37598818-20E218AB-1C53-4E78-9868-B5688B4B1F34

Q37598818-37DDCE90-9805-430A-900F-F9E00D3BC117

Q37598818-49BE1D8E-6155-48B2-A9A0-8372B956AADB

Q37598818-4A959143-9AB7-4CEF-8DF5-BA33E57DE577

Q37598818-54BBE4F4-8820-46E1-AA10-05775E95EDCF

Q37598818-58BBA80F-1DBE-46E9-BB4F-F62AAF746A36

Q37598818-63446DB0-20F5-45D8-BB25-842B067344DB

Q37598818-6A559648-B92C-45A4-A8B3-72B7C1F4AA79

P304

Q37598818-D8FB9039-E203-4E46-BF65-1D92DF5DE461

P31

Q37598818-461EF609-2CF5-44B9-8884-54380390137E

P356

Q37598818-159E5D2C-5513-422C-B675-8A395BEA14C0

P433

Q37598818-D02B423D-A6FD-4090-A5E9-57639D7EDE3B

P478

Q37598818-A3FEB50C-3848-4C3C-8332-B11A6B24BC95

P577

Q37598818-80523773-2C58-4CA7-8971-759112D6014B

P5875

Q37598818-D56DEB6F-AB70-4761-8CA8-850DFD43E29E

P698

Q37598818-51C6F5F7-4143-405D-8DDB-B1157A4AB5EF

P932

Q37598818-73E2D2EC-F7B5-46A2-88AD-42E861D14066

P356

KJIM.2014.29.1.40

P1433

The Korean journal of internal medicine

P1476

Renal adverse effects of sunit ...... le-center experience in Korea.

@en

P2093

Dong Ki Kim

http://www.w3.org/2001/XMLSchema#string

Hyunsuk Kim

http://www.w3.org/2001/XMLSchema#string

Jeonghwan Lee

http://www.w3.org/2001/XMLSchema#string

Jin Suk Han

http://www.w3.org/2001/XMLSchema#string

Kook-Hwan Oh

http://www.w3.org/2001/XMLSchema#string

Kwon-Wook Joo

http://www.w3.org/2001/XMLSchema#string

Se-Hoon Lee

http://www.w3.org/2001/XMLSchema#string

Seon Ha Baek

http://www.w3.org/2001/XMLSchema#string

Tae Min Kim

http://www.w3.org/2001/XMLSchema#string

Yon Su Kim

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Chronic VEGF blockade worsens glomerular injury in the remnant kidney model

Allergic interstitial nephritis possibly related to sunitinib use.

Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.

Nephrotic Syndrome and Acute Renal Failure Apparently Induced by Sunitinib

The case / progressive hypertension and proteinuria on anti-angiogenic therapy

Roles for VEGF in the adult.

Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma.

P304

40-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3904/KJIM.2014.29.1.40

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260397052

http://www.w3.org/2001/XMLSchema#string

P698

24574832

http://www.w3.org/2001/XMLSchema#string

P932

3932394

http://www.w3.org/2001/XMLSchema#string